serw-MX  [xml]  

 DeCS Categories

A08 Nervous System .
A08.340 Ganglia .
C04 Neoplasms .
C04.182 Cysts .
C04.182.347 Ganglion Cysts .
C10 Nervous System Diseases .
C10.228 Central Nervous System Diseases .
C10.228.140 Brain Diseases .
C10.228.140.163 Brain Diseases, Metabolic .
C10. Brain Diseases, Metabolic, Inborn .
C10. Lysosomal Storage Diseases, Nervous System .
C10. Sphingolipidoses .
C10. Gangliosidoses .
C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities .
C16.320 Genetic Diseases, Inborn .
C16.320.565 Metabolism, Inborn Errors .
C16.320.565.189 Brain Diseases, Metabolic, Inborn .
C16.320.565.189.435 Lysosomal Storage Diseases, Nervous System .
C16.320.565.189.435.825 Sphingolipidoses .
C16.320.565.189.435.825.300 Gangliosidoses .
C16.320.565.398 Lipid Metabolism, Inborn Errors .
C16.320.565.398.641 Lipidoses .
C16.320.565.398.641.803 Sphingolipidoses .
C16.320.565.398.641.803.350 Gangliosidoses .
C16.320.565.595 Lysosomal Storage Diseases .
C16.320.565.595.554 Lysosomal Storage Diseases, Nervous System .
C16.320.565.595.554.825 Sphingolipidoses .
C16.320.565.595.554.825.300 Gangliosidoses .
C17 Skin and Connective Tissue Diseases .
C17.300 Connective Tissue Diseases .
C17.300.550 Mucinoses .
C17.300.550.274 Ganglion Cysts .
C18 Nutritional and Metabolic Diseases .
C18.452 Metabolic Diseases .
C18.452.132 Brain Diseases, Metabolic .
C18.452.132.100 Brain Diseases, Metabolic, Inborn .
C18.452.132.100.435 Lysosomal Storage Diseases, Nervous System .
C18.452.132.100.435.825 Sphingolipidoses .
C18.452.132.100.435.825.300 Gangliosidoses .
C18.452.584 Lipid Metabolism Disorders .
C18.452.584.687 Lipidoses .
C18.452.584.687.803 Sphingolipidoses .
C18.452.584.687.803.350 Gangliosidoses .
C18.452.648 Metabolism, Inborn Errors .
C18.452.648.189 Brain Diseases, Metabolic, Inborn .
C18.452.648.189.435 Lysosomal Storage Diseases, Nervous System .
C18.452.648.189.435.825 Sphingolipidoses .
C18.452.648.189.435.825.300 Gangliosidoses .
C18.452.648.398 Lipid Metabolism, Inborn Errors .
C18.452.648.398.641 Lipidoses .
C18.452.648.398.641.803 Sphingolipidoses .
C18.452.648.398.641.803.350 Gangliosidoses .
C18.452.648.595 Lysosomal Storage Diseases .
C18.452.648.595.554 Lysosomal Storage Diseases, Nervous System .
C18.452.648.595.554.825 Sphingolipidoses .
C18.452.648.595.554.825.300 Gangliosidoses .
D09 Carbohydrates .
D09.400 Glycoconjugates .
D09.400.410 Glycolipids .
D09.400.410.420 Glycosphingolipids .
D09.400.410.420.025 Acidic Glycosphingolipids .
D09.400.410.420.025.475 Gangliosides .
D09.400.410.420.025.475.400 G(M2) Ganglioside .
D09.400.410.420.025.475.510 G(M3) Ganglioside .
D10 Lipids .
D10.390 Glycolipids .
D10.390.470 Glycosphingolipids .
D10.390.470.025 Acidic Glycosphingolipids .
D10.390.470.025.475 Gangliosides .
D10.390.470.025.475.400 G(M2) Ganglioside .
D10.390.470.025.475.510 G(M3) Ganglioside .
D10.570 Membrane Lipids .
D10.570.877 Sphingolipids .
D10.570.877.360 Glycosphingolipids .
D10.570.877.360.025 Acidic Glycosphingolipids .
D10.570.877.360.025.475 Gangliosides .
D10.570.877.360.025.475.400 G(M2) Ganglioside .
D10.570.877.360.025.475.510 G(M3) Ganglioside .
 Synonyms & Historicals
Gangliosides .
Sialoglycosphingolipids .
A subclass of ACIDIC GLYCOSPHINGOLIPIDS. They contain one or more sialic acid (N-ACETYLNEURAMINIC ACID) residues. Using the Svennerholm system of abbrevations, gangliosides are designated G for ganglioside, plus subscript M, D, or T for mono-, di-, or trisialo, respectively, the subscript letter being followed by a subscript arabic numeral to indicated sequence of migration in thin-layer chromatograms. (From Oxford Dictionary of Biochemistry and Molecular Biology, 1997) .
Gangliosidoses .
Ganglioside Storage Diseases .
Ganglioside Storage Disorders .
Gangliosidosis .
Ganglioside Storage Disease .
Ganglioside Storage Disorder .
Storage Disease, Ganglioside .
Storage Diseases, Ganglioside .
Storage Disorder, Ganglioside .
Storage Disorders, Ganglioside .
A group of autosomal recessive lysosomal storage disorders marked by the accumulation of GANGLIOSIDES. They are caused by impaired enzymes or defective cofactors required for normal ganglioside degradation in the LYSOSOMES. Gangliosidoses are classified by the specific ganglioside accumulated in the defective degradation pathway. .
Ganglion Cysts .
Ganglionic Cysts .
Ganglions .
Cyst, Ganglion .
Cyst, Ganglionic .
Cyst, Myxoid .
Cysts, Ganglion .
Cysts, Ganglionic .
Cysts, Myxoid .
Ganglion .
Ganglion Cyst .
Ganglionic Cyst .
Myxoid Cysts .
Myxoid Cyst .
Nodular tumor-like lesions or mucoid flesh, arising from tendon sheaths, LIGAMENTS, or JOINT CAPSULE, especially of the hands, wrists, or feet. They are not true cysts as they lack epithelial wall. They are distinguished from SYNOVIAL CYSTS by the lack of communication with a joint cavity or the SYNOVIAL MEMBRANE. .
G(M2) Ganglioside .
Ganglioside GM2 .
GM2, Ganglioside .
Ganglioside, Tay-Sachs Disease .
Tay Sachs Disease Ganglioside .
Tay-Sachs Disease Ganglioside .
A glycosphingolipid that accumulates due to a deficiency of hexosaminidase A or B (BETA-N-ACETYLHEXOSAMINIDASES), or GM2 activator protein, resulting in GANGLIOSIDOSES, heredity metabolic disorders that include TAY-SACHS DISEASE and SANDHOFF DISEASE. .
Ganglia .
Clusters of multipolar neurons surrounded by a capsule of loosely organized CONNECTIVE TISSUE located outside the CENTRAL NERVOUS SYSTEM. .
G(M3) Ganglioside .
Ganglioside GM3 .
II3NeuAcLacCer .
Sialyl Lactosylceramide .
GM3, Ganglioside .
Lactosylceramide, Sialyl .
Hematoside .
Sialyllactosylceramide .
A ganglioside present in abnormally large amounts in the brain and liver due to a deficient biosynthetic enzyme, G(M3):UDP-N-acetylgalactosaminyltransferase. Deficiency of this enzyme prevents the formation of G(M2) ganglioside from G(M3) ganglioside and is the cause of an anabolic sphingolipidosis. .